Cvijic Christine Mikail
Insider CIK 1543663 · DNDN EVP, Corp Dev, Gen Counsel · NGNE President and CFO, Director · AXON Chief Admin Officer and GC · NPSP SVP, Legal Affairs & GC
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NGNE Neurogene Inc. | S Sale | 2026-07-07 | 2026-07-07 | 4,200 | $36.13 | $151.7K | 84,040 | SEC↗ |
| NGNE Neurogene Inc. | S Sale | 2026-07-06 | 2026-07-07 | 600 | $36.02 | $21.6K | 88,240 | SEC↗ |
| NGNE Neurogene Inc. | S Sale | 2026-07-02 | 2026-07-02 | 1,530 | $35.23 | $53.9K | 88,840 | SEC↗ |
| NGNE Neurogene Inc. | S Sale | 2026-07-02 | 2026-07-02 | 2,531 | $34.58 | $87.5K | 90,370 | SEC↗ |
| NGNE Neurogene Inc. | S Sale | 2026-07-01 | 2026-07-02 | 739 | $34.06 | $25.2K | 92,901 | SEC↗ |
| NGNE Neurogene Inc. | S Sale | 2026-05-06 | 2026-05-08 | 4,800 | $30.07 | $144.3K | 98,440 | SEC↗ |
| NGNE Neurogene Inc. | S Sale | 2026-05-06 | 2026-05-08 | 4,800 | $32.44 | $155.7K | 93,640 | SEC↗ |
| NGNE Neurogene Inc. | S Sale | 2026-03-26 | 2026-03-30 | 2,558 | $21.62 | $55.3K | 103,240 | SEC↗ |
| NGNE Neurogene Inc. | S Sale | 2026-03-13 | 2026-03-17 | 2,387 | $20.42 | $48.7K | 107,456 | SEC↗ |
| NGNE Neurogene Inc. | S Sale | 2026-03-13 | 2026-03-17 | 1,395 | $21.25 | $29.6K | 106,061 | SEC↗ |
| NGNE Neurogene Inc. | S Sale | 2026-03-13 | 2026-03-17 | 263 | $22.02 | $5.8K | 105,798 | SEC↗ |
| NGNE Neurogene Inc. | S Sale | 2026-02-27 | 2026-03-03 | 4,800 | $25.11 | $120.5K | 109,843 | SEC↗ |
| NGNE Neurogene Inc. | A Award deriv | 2026-02-20 | 2026-02-24 | 131,900 | — | $0 | 131,900 | SEC↗ |
| NGNE Neurogene Inc. | A Award | 2026-02-20 | 2026-02-24 | 22,000 | — | $0 | 114,643 | SEC↗ |
| NGNE Neurogene Inc. | A Award deriv | 2025-03-26 | 2025-03-28 | 122,000 | — | $0 | 122,000 | SEC↗ |
| NGNE Neurogene Inc. | A Award | 2025-03-26 | 2025-03-28 | 20,300 | — | $0 | 92,643 | SEC↗ |
| NGNE Neurogene Inc. | S Sale | 2025-03-13 | 2025-03-17 | 4,501 | $16.94 | $76.2K | 72,343 | SEC↗ |
| NGNE Neurogene Inc. | P Buy | 2024-11-22 | 2024-11-25 | 24,000 | $20.48 | $491.5K | 76,844 | SEC↗ |
| NGNE Neurogene Inc. | A Award deriv | 2024-03-13 | 2024-03-14 | 53,900 | — | $0 | 53,900 | SEC↗ |
| NGNE Neurogene Inc. | A Award | 2024-03-13 | 2024-03-14 | 31,903 | — | $0 | 52,844 | SEC↗ |
| AXON Axovant Sciences Ltd. | A Award deriv | 2016-04-29 | 2016-05-03 | 50,000 | — | $0 | 50,000 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 29,085 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 79,453 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | D To issuer deriv | 2015-02-21 | 2015-02-24 | 10,905 | — | $0 | 0 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2015-02-12 | 2015-02-20 | 10,905 | — | $0 | 10,905 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2014-04-15 | 2014-04-17 | 29,085 | — | $0 | 29,085 | SEC↗ |
| NPSP NPS PHARMACEUTICALS INC | A Award deriv | 2014-04-15 | 2014-04-17 | 79,453 | — | $0 | 79,453 | SEC↗ |
| DNDN DENDREON CORP | F Tax w/h | 2014-02-10 | 2014-02-12 | 6,167 | $2.81 | $17.3K | 351,465 | SEC↗ |
| DNDN DENDREON CORP | A Award | 2014-02-10 | 2014-02-12 | 17,956 | — | $0 | 357,632 | SEC↗ |
| DNDN DENDREON CORP | F Tax w/h | 2014-01-03 | 2014-01-07 | 9,456 | $3.08 | $29.1K | 339,676 | SEC↗ |
| DNDN DENDREON CORP | A Award | 2014-01-03 | 2014-01-07 | 200,000 | — | $0 | 349,132 | SEC↗ |
| DNDN DENDREON CORP | F Tax w/h | 2013-12-08 | 2013-12-10 | 1,380 | $3.01 | $4.2K | 149,132 | SEC↗ |
| DNDN DENDREON CORP | F Tax w/h | 2013-09-08 | 2013-09-09 | 1,380 | $2.88 | $4.0K | 150,512 | SEC↗ |
| DNDN DENDREON CORP | F Tax w/h | 2013-06-08 | 2013-06-10 | 1,380 | $3.90 | $5.4K | 151,892 | SEC↗ |
| DNDN DENDREON CORP | F Tax w/h | 2013-03-08 | 2013-03-12 | 5,520 | $5.91 | $32.6K | 153,272 | SEC↗ |
| DNDN DENDREON CORP | A Award | 2013-01-03 | 2013-01-07 | 94,502 | — | $0 | 158,792 | SEC↗ |
| DNDN DENDREON CORP | A Award deriv | 2012-03-08 | 2012-03-12 | 128,580 | $10.12 | $1.30M | 128,580 | SEC↗ |
| DNDN DENDREON CORP | A Award | 2012-03-08 | 2012-03-12 | 64,290 | — | $0 | 64,290 | SEC↗ |